KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the Company’s lead oncology agent PV-10 at a seventh major center located at the University of Louisville, in Louisville, KY. Charles Scoggins, M.D. will serve as principal investigator at the new center.
